Pharmaceutical Granulation Equipment Market Size (2024 - 2029)

Pharmaceutical Granulation Equipment Market Analysis

The Pharmaceutical Granulation Equipment Market is expected to register a CAGR of 5.60% during the forecast period.

The market is driven by the increasing number of research laboratories, growing healthcare R&D expenditures, and product launches.

The increasing research and development in the field of life sciences and huge public and private funding in the sector are boosting the market's growth. For instance, the Indian Ministry of Science and Technology allocated a budget of INR 40 billion (USD 427.20 million) for the Department of Biotechnology (DBT) of India in the Union Budget for 2023-2024, an INR 1,100 crore budget allocated primarily for biotechnology research and development as well as industrial and entrepreneurship development in the country, which is expected to boost the studied market.

In addition, the National Institute of Health (NIH) invested USD 18,002 million in 2022 compared to USD 17,681 million in 2022 for its research activities associated with various chronic diseases, cancer, cardiology diseases, and Alzheimer's. This investment by government organizations contributes to the rising importance of biopharmaceuticals and thus boosts the demand for pharmaceutical granulation equipment, boosting the market's growth.

Further, the increasing number of pharmaceutical research laboratories is expected to increase the need for granulation equipment for the formulation, thereby boosting market growth. For instance, in October 2023, the National Laboratory of Pharmaceutical Research and Development (PharmaLab) was founded by the ELKH Research Centre for Natural Sciences (TTK). Its primary goal is to pioneer therapeutic and diagnostic solutions. Additionally, PharmaLab focuses on creating eco-friendly and cost-effective methods for producing active substances and drug formulations. These innovations are specifically tailored for treating various diseases, ranging from oncological and immunological to neurological ailments. The establishment of such laboratories tends to increase the demand for granulation equipment, thereby boosting the market's growth.

Moreover, strategic activities by the market players, such as strategic acquisition and partnership for the distribution and commercialization of granulation equipment, are expected to contribute to the market's growth. For instance, in March 2023, Prochem, one of the leaders in API powder handling solutions for various domains, acquired Tapasya. It is a company involved in granulation and a single-stop solution provider of solid formulations for the pharmaceutical, nutraceutical, specialty, agro, and food industries.

Thus, increasing R&D expenditure in pharmaceuticals, the growing establishment of pharmaceutical laboratories, and strategic initiatives taken by the market players are expected to boost the market's growth during the forecast period. However, the high cost of equipment is expected to hinder the market's growth during the forecast period.

Pharmaceutical Granulation Equipment Industry Segmentation

As per the scope of the report, granulation is the process of particle enlargement by agglomeration technique to provide a more homogenous mixture with the formation of granules by agglomeration of fine particles.

The pharmaceutical granulation equipment market is segmented by type, mechanism, end user, and geography. By type, the market is segmented as single pot granulators, high sheer granulators, oscillating granulators, and other types. By mechanism, the market is segmented as dry granulators, wet granulators, and mixture granulators. By end user, the market is segmented as pharmaceutical manufacturing companies, contract manufacturing, and other end users. By geography, the market is segmented as North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report offers the value (USD) for the above segments.